首页 > 市场调查报告书 > 製药

疫苗动物用医药

市场调查报告书

商品编码

1668001

宠物疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按动物类型、按疫苗接种、按给药方式、按地区和竞争进行细分，2020-2030 年预测

Pet Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Vaccination, By Mode Of Administration, By Region and Competition, 2020-2030F

出版日期: 2025年02月28日 | 出版商:

TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球宠物疫苗市场价值为 113.1 亿美元，预计到 2030 年将达到 161 亿美元，复合年增长率为 6.04%。随着宠物拥有量的不断增加，人们越来越重视预防性医疗保健，包括接种疫苗，以保护动物免受传染病的侵害。兽医保健技术的进步促进了更有效疫苗的开发，确保更好地预防狂犬病、犬瘟热和细小病毒等疾病。随着兽医服务的普及以及透过诊所、医院和线上平台获得宠物疫苗的机会的增加，进一步促进了市场的扩张。製造商正在投入研发，以推出疗效更强、保护时间更长的下一代疫苗。

市场概况
预测期	2026-2030
2024 年市场规模	113.1 亿美元
2030 年市场规模	161亿美元
2025-2030 年复合年增长率	6.04%
成长最快的领域	鼻内疫苗
最大的市场	北美洲

生物技术的创新以及 DNA 和重组疫苗的兴起正在改变市场格局。公司正专注于开发联合疫苗，只需注射一次即可提供针对多种疾病的免疫力，减少宠物看兽医的频率并提高宠物的依从性。伴侣动物疫苗（尤其是狗和猫疫苗）的需求不断增长，推动了市场成长。政府推动动物疫苗接种计划的倡议和强制免疫的严格规定正在增强市场活力。宠物保险覆盖范围的扩大（越来越多地包括疫苗接种费用）正在鼓励宠物主人投资预防性医疗保健。可支配收入的增加和宠物的人性化（主人将动物视为家庭成员）也助长了宠物疫苗需求的不断增长。

主要市场驱动因素

伴侣动物疾病盛行率不断上升

主要市场挑战

疫苗接种成本高昂

主要市场趋势

个人化宠物疫苗需求不断成长

Global Pet Vaccine Market was valued at USD 11.31 Billion in 2024 and is expected to reach USD 16.10 Billion in the forecast period with a CAGR of 6.04% through 2030. The global pet vaccine market is experiencing significant growth, driven by increasing pet adoption and rising awareness about animal health. As pet ownership continues to rise, there is a growing emphasis on preventive healthcare, including vaccination, to protect animals from infectious diseases. Veterinary healthcare advancements have led to the development of more effective vaccines, ensuring better protection against diseases such as rabies, distemper, and parvovirus. The expanding availability of veterinary services and improved access to pet vaccines through clinics, hospitals, and online platforms are further contributing to market expansion. Manufacturers are investing in research and development to introduce next-generation vaccines with enhanced efficacy and longer protection duration.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 11.31 Billion
Market Size 2030	USD 16.10 Billion
CAGR 2025-2030	6.04%
Fastest Growing Segment	Intranasal Vaccines
Largest Market	North America

Innovations in biotechnology and the rise of DNA and recombinant vaccines are transforming the market landscape. Companies are focusing on developing combination vaccines that provide immunity against multiple diseases with a single shot, reducing the frequency of veterinary visits and improving pet compliance. The rising demand for companion animal vaccines, particularly for dogs and cats, is fueling market growth. Government initiatives promoting animal vaccination programs and stringent regulations mandating immunization are strengthening market dynamics. The expansion of pet insurance coverage, which increasingly includes vaccination costs, is encouraging pet owners to invest in preventive healthcare. Increasing disposable income and the humanization of pets, where owners treat animals as family members, are also contributing to the growing demand for pet vaccines.

Key Market Drivers

Increasing Prevalence of Diseases in Companion Animals

The increasing prevalence of diseases in companion animals is a significant driver of the global pet vaccine market. In 2023, the World Health Organization (WHO) reported that rabies causes an estimated 59,000 human deaths annually, with dogs responsible for 99% of these transmissions. This alarming statistic underscores the critical need for effective vaccination programs to control rabies in canine populations, thereby protecting both animal and human health. Similarly, the WHO has highlighted concerns about psittacosis, a zoonotic disease transmitted from birds to humans. In February 2024, several European countries, including Austria, Denmark, Germany, Sweden, and the Netherlands, reported an increase in psittacosis cases observed in 2023 and early 2024, particularly since November-December 2023. These instances exemplify the rising incidence of zoonotic diseases, emphasizing the necessity for comprehensive vaccination strategies in companion animals.

Veterinary professionals and regulatory bodies are actively promoting routine vaccination schedules to curb the spread of these highly contagious diseases among pets. Government-led initiatives and vaccination mandates in several countries are reinforcing immunization practices, ensuring broader coverage among companion animals. For instance, the WHO recommends that vaccinating at least 70% of dogs in areas at risk is the most effective way of preventing human rabies deaths. This strategy not only safeguards animal health but also significantly reduces the risk of zoonotic disease transmission to humans. The increasing urbanization and closer human-animal interactions have raised concerns about zoonotic disease transmission, prompting pet owners to prioritize vaccinations as a preventive measure. In densely populated areas, the risk of disease outbreaks among pets is higher, making immunization an essential part of pet healthcare.

The increasing number of pet owners worldwide has been a driving force behind the expansion of veterinary healthcare facilities. For example, in countries such as the United States, over 90 million households now own pets, which has created a larger market for pet healthcare services. This surge in pet ownership has prompted veterinary clinics to expand their operations and offer more comprehensive healthcare solutions. At the same time, advancements in veterinary care, such as improved diagnostic tools and treatment options, have made it easier for clinics to provide effective care, including timely vaccinations for pets.

Government initiatives also play a crucial role in supporting the growth of veterinary healthcare infrastructure. Several countries have implemented programs to promote animal health and strengthen the veterinary workforce, including funding for veterinary clinics and training for veterinary professionals. This, in turn, ensures greater access to vaccines for pets and contributes to higher vaccination rates. As more pet owners seek professional care for their animals, the demand for dog vaccines continues to rise, further fueling the market's growth. Improved infrastructure and government support are creating a favorable environment for increased pet vaccination, thereby driving the expansion of the pet vaccine market.

Key Market Challenges

High Cost of Vaccination

One of the major challenges facing the global pet vaccine market is the high cost of vaccination, which can limit access to essential preventive healthcare for pets, particularly in lower-income regions. The price of vaccines varies depending on the type of vaccine, the brand, and the country in which they are administered. Vaccination costs are influenced by several factors, including the research and development expenses involved in creating new vaccines, regulatory fees, and distribution costs. For example, combination vaccines, which provide protection against multiple diseases in one dose, can be more expensive than single vaccines, further escalating the overall cost for pet owners.

In addition to the direct costs of vaccines, pet owners may incur additional charges for veterinary consultations and health assessments to determine which vaccines are needed for their dogs. This makes the vaccination process financially challenging for individuals, especially in regions where veterinary care is not subsidized or where pet healthcare is not covered by insurance. According to a report from the American Kennel Club, a basic vaccination package for a dog in the U.S. can cost anywhere from USD 75 to USD 150, depending on the vaccines included. More advanced vaccines or those for rare diseases may cost even more. These costs can be a significant burden for pet owners in developing countries or low-income households, potentially resulting in lower vaccination rates.

Key Market Trends

Increasing Demand for Personalized Pet Vaccines

The increasing demand for personalized pet vaccines represents a notable trend in the Pet Vaccine Market. This trend reflects a growing recognition that not all pets are alike, and tailoring vaccines to an individual animal's specific needs can yield significant benefits. Personalized pet vaccines involve customizing vaccination schedules and formulations based on factors such as a pet's age, breed, lifestyle, and geographic location. This approach ensures that each pet receives the most appropriate and effective protection against diseases, optimizing their overall health and minimizing unnecessary vaccinations. Advances in veterinary diagnostics, including genetic testing and serological assays, allow for a more precise understanding of a pet's immune status and susceptibility to specific diseases. This information can inform personalized vaccine recommendations. Pet owners increasingly view their pets as members of the family and are willing to invest in their well-being. They seek out veterinary practices that offer tailored healthcare plans, including personalized vaccines, to ensure the best outcomes for their pets.

Concerns about over-vaccination have led to a more selective approach to vaccinations. Personalization allows veterinarians to minimize unnecessary vaccinations, reducing the potential for adverse reactions and vaccine-related health issues. Regional disease prevalence varies, and some areas may have specific disease risks. Personalized vaccines can address these geographical variations, providing pets with targeted protection. In summary, the demand for personalized pet vaccines is driven by a shift toward individualized pet care and a desire to optimize vaccine effectiveness while minimizing risks. This trend aligns with the broader movement toward personalized medicine and is likely to continue shaping the Pet Vaccine Market in the coming years.

Key Market Players

Bayer AG
Elanco US Inc.
Merck KGaA
Merial Inc.
Virbac SA
Zoetis Inc
Phibro Animal Health Corporation
Boehringer Ingelheim GmbH
Tianjin Ringpu Bio-Technology Co., Ltd
Vetoquinol SA

Report Scope:

In this report, the Global Pet Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Vaccine Market, By Animal Type:

Canine
Feline
Equine

Pet Vaccine Market, By Vaccination:

Canine Family
Feline Family
Others

Pet Vaccine Market, By Mode Of Administration:

Injectable Vaccines
Intranasal Vaccines

Pet Vaccine Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Pet Vaccine Market.

Available Customizations:

Global Pet Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pet Vaccine Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Animal Type (Canine, Feline, Equine)
- 5.2.2. By Vaccination (Canine Family, Feline Family, Others)
- 5.2.3. By Mode Of Administration (Injectable Vaccines, Intranasal Vaccines)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
5.3. Market Map

6. North America Pet Vaccine Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Animal Type
- 6.2.2. By Vaccination
- 6.2.3. By Mode Of Administration
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Pet Vaccine Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Animal Type
    - 6.3.1.2.2. By Vaccination
    - 6.3.1.2.3. By Mode Of Administration
- 6.3.2. Mexico Pet Vaccine Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Animal Type
    - 6.3.2.2.2. By Vaccination
    - 6.3.2.2.3. By Mode Of Administration
- 6.3.3. Canada Pet Vaccine Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Animal Type
    - 6.3.3.2.2. By Vaccination
    - 6.3.3.2.3. By Mode Of Administration

7. Europe Pet Vaccine Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Animal Type
- 7.2.2. By Vaccination
- 7.2.3. By Mode Of Administration
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Pet Vaccine Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Animal Type
    - 7.3.1.2.2. By Vaccination
    - 7.3.1.2.3. By Mode Of Administration
- 7.3.2. Germany Pet Vaccine Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Animal Type
    - 7.3.2.2.2. By Vaccination
    - 7.3.2.2.3. By Mode Of Administration
- 7.3.3. United Kingdom Pet Vaccine Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Animal Type
    - 7.3.3.2.2. By Vaccination
    - 7.3.3.2.3. By Mode Of Administration
- 7.3.4. Italy Pet Vaccine Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Animal Type
    - 7.3.4.2.2. By Vaccination
    - 7.3.4.2.3. By Mode Of Administration
- 7.3.5. Spain Pet Vaccine Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Animal Type
    - 7.3.5.2.2. By Vaccination
    - 7.3.5.2.3. By Mode Of Administration

8. Asia-Pacific Pet Vaccine Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Animal Type
- 8.2.2. By Vaccination
- 8.2.3. By Mode Of Administration
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Pet Vaccine Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Animal Type
    - 8.3.1.2.2. By Vaccination
    - 8.3.1.2.3. By Mode Of Administration
- 8.3.2. India Pet Vaccine Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Animal Type
    - 8.3.2.2.2. By Vaccination
    - 8.3.2.2.3. By Mode Of Administration
- 8.3.3. South Korea Pet Vaccine Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Animal Type
    - 8.3.3.2.2. By Vaccination
    - 8.3.3.2.3. By Mode Of Administration
- 8.3.4. Japan Pet Vaccine Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Animal Type
    - 8.3.4.2.2. By Vaccination
    - 8.3.4.2.3. By Mode Of Administration
- 8.3.5. Australia Pet Vaccine Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Animal Type
    - 8.3.5.2.2. By Vaccination
    - 8.3.5.2.3. By Mode Of Administration

9. South America Pet Vaccine Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Animal Type
- 9.2.2. By Vaccination
- 9.2.3. By Mode Of Administration
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Pet Vaccine Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Animal Type
    - 9.3.1.2.2. By Vaccination
    - 9.3.1.2.3. By Mode Of Administration
- 9.3.2. Argentina Pet Vaccine Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Animal Type
    - 9.3.2.2.2. By Vaccination
    - 9.3.2.2.3. By Mode Of Administration
- 9.3.3. Colombia Pet Vaccine Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Animal Type
    - 9.3.3.2.2. By Vaccination
    - 9.3.3.2.3. By Mode Of Administration

10. Middle East and Africa Pet Vaccine Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Animal Type
- 10.2.2. By Vaccination
- 10.2.3. By Mode Of Administration
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Pet Vaccine Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Animal Type
    - 10.3.1.2.2. By Vaccination
    - 10.3.1.2.3. By Mode Of Administration
- 10.3.2. Saudi Arabia Pet Vaccine Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Animal Type
    - 10.3.2.2.2. By Vaccination
    - 10.3.2.2.3. By Mode Of Administration
- 10.3.3. UAE Pet Vaccine Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Animal Type
    - 10.3.3.2.2. By Vaccination
    - 10.3.3.2.3. By Mode Of Administration

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Bayer AG
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Elanco US Inc.
14.3. Merck KGaA
14.4. Merial Inc.
14.5. Virbac SA
14.6. Zoetis Inc
14.7. Phibro Animal Health Corporation
14.8. Boehringer Ingelheim GmbH
14.9. Tianjin Ringpu Bio-Technology Co., Ltd
14.10. Vetoquinol SA